MedPath

Impact of a Free Distribution of Paracetamol to Osteoarthritic Patients on Non-steroidal Anti-inflammatory Drugs (NSAID) and Proton Pump Inhibitors (PPI) Prescription

Not Applicable
Completed
Conditions
Osteoarthritis
Interventions
Other: free paracetamol
Registration Number
NCT02691754
Lead Sponsor
Azienda Unità Sanitaria Locale Reggio Emilia
Brief Summary

Paracetamol is recommended as first line treatment for pain control in osteoarthritis, but it is not included in list of drugs than can be prescribed in charge of National Health System by General Practitioners. The hypothesis is that removing this economical barrier the investigators can decrease the prescription of NSAID and of the Proton Pump Inhibitors (PPI), often given for gastric bleeding prophylaxis in NSAID chronic users. As secondary outcome, opioids use was also monitored to see.

Aim of the study is to test if allowing prescription of free paracetamol decreases the prescription of NSAID in osteoarthritic patients.

Detailed Description

The trial was conducted in two primary care units of the province of Reggio Emilia. The units have about 34.000 inhabitants. In this units 16 General Practitioners are active, the average beneficiaries per General Practitioner are 1500, about one fourth over 65 years old.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Patients with osteoarthritis assisted by a General Practitioners working in Reggio Emilia Province who agreed to participate in the study
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
free paracetamolfree paracetamolthe General Practitioners can prescribe paracetamol for free (covered by NHS). Patients can receive monthly dose at the local hospital
Primary Outcome Measures
NameTimeMethod
Consumption of NSAIDone year

Difference in defined daily dose (DDD) per patient between the control and the intervention

Secondary Outcome Measures
NameTimeMethod
Consumption of PPIone year

Difference in defined daily dose (DDD) per patient between the control and the intervention

Consumption of opioidsone year

Difference in defined daily dose (DDD) per patient between the control and the intervention

© Copyright 2025. All Rights Reserved by MedPath